home / stock / clrb / clrb quote
Last: | $3.33 |
---|---|
Change Percent: | 0.6% |
Open: | $3.34 |
Close: | $3.33 |
High: | $3.45 |
Low: | $3.295 |
Volume: | 472,266 |
Last Trade Date Time: | 05/16/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$3.33 | $3.34 | $3.33 | $3.45 | $3.295 | 472,266 | 05-16-2024 |
$3.36 | $3.25 | $3.36 | $3.4899 | $3.23 | 1,107,323 | 05-15-2024 |
$3.18 | $3.02 | $3.18 | $3.22 | $3 | 675,499 | 05-14-2024 |
$3.06 | $3.08 | $3.06 | $3.16 | $2.98 | 640,388 | 05-13-2024 |
$3.07 | $3.25 | $3.07 | $3.25 | $3.05 | 1,118,622 | 05-10-2024 |
$3.24 | $3.2 | $3.24 | $3.25 | $3.175 | 180,512 | 05-09-2024 |
$3.2 | $3.28 | $3.2 | $3.3 | $3.145 | 373,821 | 05-08-2024 |
$3.29 | $3.32 | $3.29 | $3.35 | $3.18 | 742,025 | 05-07-2024 |
$3.33 | $3.45 | $3.33 | $3.48 | $3.31 | 714,330 | 05-06-2024 |
$3.42 | $3.34 | $3.42 | $3.51 | $3.34 | 510,738 | 05-03-2024 |
$3.34 | $3.29 | $3.34 | $3.41 | $3.25 | 644,930 | 05-02-2024 |
$3.16 | $3.1 | $3.16 | $3.33 | $3.08 | 963,527 | 05-01-2024 |
$3.09 | $3.1 | $3.09 | $3.14 | $3.04 | 533,925 | 04-30-2024 |
$3.1 | $3.03 | $3.1 | $3.2 | $3.025 | 716,440 | 04-29-2024 |
$3.03 | $3.04 | $3.03 | $3.12 | $2.98 | 686,677 | 04-26-2024 |
$3.02 | $3.07 | $3.02 | $3.1 | $2.942 | 690,802 | 04-25-2024 |
$3.06 | $3.09 | $3.06 | $3.175 | $3 | 1,043,185 | 04-24-2024 |
$3.11 | $3.17 | $3.11 | $3.2793 | $3.11 | 897,754 | 04-23-2024 |
$3.19 | $3.03 | $3.19 | $3.2288 | $2.96 | 866,660 | 04-22-2024 |
$3.03 | $3.03 | $3.03 | $3.16 | $3.01 | 806,967 | 04-19-2024 |
News, Short Squeeze, Breakout and More Instantly...
Cellectar Biosciences Inc. Company Name:
CLRB Stock Symbol:
NASDAQ Market:
Cellectar Biosciences Inc. Website:
Management to host a conference call today at 8:30 am ET WM pivotal study data to be announced in June FLORHAM PARK, N.J., May 14, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, develop...
FLORHAM PARK, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ:CLRB), a late-stage clinical biopharmaceutical company ...
FLORHAM PARK, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced that Jarrod Longcor, chief operating ...